Literature DB >> 19416290

Concomitant human granulocytic anaplasmosis and Lyme neuroborreliosis.

S Lotric-Furlan1, E Ruzic-Sabljic, F Strle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19416290     DOI： 10.1111/j.1469-0691.2008.02145.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

Review 1.  Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.

Authors:  Igor Dumic; Dorde Jevtic; Mladjen Veselinovic; Charles W Nordstrom; Milan Jovanovic; Vanajakshi Mogulla; Elmira Mofid Veselinovic; Ann Hudson; Gordana Simeunovic; Emilia Petcu; Poornima Ramanan
Journal:  Microorganisms       Date:  2022-07-15

2.  Are patients with erythema migrans who have leukopenia and/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus?

Authors:  Franc Strle; Petra Bogovič; Jože Cimperman; Vera Maraspin; Katarina Ogrinc; Tereza Rojko; Daša Stupica; Lara Lusa; Tatjana Avšič-Županc; Katja Strašek Smrdel; Mateja Jelovšek; Stanka Lotrič-Furlan
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

3.  Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Authors:  Ruben Magni; Benjamin H Espina; Ketul Shah; Benjamin Lepene; Christine Mayuga; Temple A Douglas; Virginia Espina; Sally Rucker; Ross Dunlap; Emanuel F Iii Petricoin; Mary Frekko Kilavos; Donald M Poretz; Gilbert R Irwin; Samuel M Shor; Lance A Liotta; Alessandra Luchini
Journal:  J Transl Med       Date:  2015-11-04       Impact factor: 5.531

Review 4.  A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe.

Authors:  Ioana A Matei; Agustín Estrada-Peña; Sally J Cutler; Muriel Vayssier-Taussat; Lucía Varela-Castro; Aleksandar Potkonjak; Herve Zeller; Andrei D Mihalca
Journal:  Parasit Vectors       Date:  2019-12-21       Impact factor: 3.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.